In this podcast, Finnegan attorneys Mark Feldstein, Cora Holt, and Tom Irving discuss the impacts of the recent Federal Circuit cases GSK v. Teva and Amarin v. Hikma.
A closed captioning version is available here.
United States Court of Appeals for the Federal Circuit (CAFC), drugs, Food and Drug Administration (FDA)
Lecture
Patent Protection for Software-Related Inventions in Europe and the USA Training Course
June 5, 2024
Hybrid
Webinar
Obviousness of Biologics Inventions: Strategies for Biologics Claims in the U.S., Europe, and China
May 28,2024
Webinar
INCONTESTABLE® Blog
May 3, 2024
Prosecution First Blog
May 3, 2024
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.